RRC ID 10761
著者 Murata N, Murakami K, Ozawa Y, Kinoshita N, Irie K, Shirasawa T, Shimizu T.
タイトル Silymarin attenuated the amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer's disease mouse model.
ジャーナル Biosci Biotechnol Biochem
Abstract Alzheimer's disease (AD) is characterized by progressive cognitive impairment and the formation of senile plaques. Silymarin, an extract of milk thistle, has long been used as a medicinal herb for liver diseases. Here we report marked suppression of amyloid β-protein (Aβ) fibril formation and neurotoxicity in PC12 cells after silymarin treatment in vitro. In vivo studies had indicated a significant reduction in brain Aβ deposition and improvement in behavioral abnormalities in amyloid precursor protein (APP) transgenic mice that had been preventively treated with a powdered diet containing 0.1% silymarin for 6 months. The silymarin-treated APP mice also showed less anxiety than the vehicle-treated APP mice. These behavioral changes were associated with a decline in Aβ oligomer production induced by silymarin intake. These results suggest that silymarin is a promising agent for the prevention of AD.
巻・号 74(11)
ページ 2299-306
公開日 2010-1-1
DOI 10.1271/bbb.100524
PII JST.JSTAGE/bbb/100524
PMID 21071836
MeSH Alzheimer Disease / drug therapy* Alzheimer Disease / prevention & control Animals Disease Models, Animal Mental Disorders / drug therapy* Mice Mice, Transgenic PC12 Cells Plaque, Amyloid / complications Plaque, Amyloid / drug therapy* Protective Agents Rats Silymarin / pharmacology* Silymarin / therapeutic use
IF 1.516
引用数 39
WOS 分野 FOOD SCIENCE & TECHNOLOGY CHEMISTRY, APPLIED BIOTECHNOLOGY & APPLIED MICROBIOLOGY BIOCHEMISTRY & MOLECULAR BIOLOGY
リソース情報
ヒト・動物細胞 PC-12(RCB0009)